Haemonetics
Mr. Abernathy joined our Board in 2017 and is Chair of the Compensation Committee and a member of the Technology Committee. From October 2014 until his retirement in June 2017, Mr. Abernathy served as Chairman and Chief Executive Officer of Halyard Health Inc., a medical technology company and spin-off from Kimberly-Clark (he continued as Chairman until September 2017). Previously, he held roles of increasing responsibility with Kimberly-Clark Corporation, including President of Kimberly Clark’s Global Healthcare business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Haemonetics
7 followers
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare.